Sign up

First Light Asset Management, LLC

$1.6B assets · 31 holdings · Q2 2026 · Filed 14 AUG 2026

About First Light Asset Management, LLC’s 13F portfolio

First Light Asset Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , First Light Asset Management, LLC reported $1.6B across 31 US-listed positions (). Its largest position is NEOGENOMICS INC (NEO) at 11% of the reported book, and its ten biggest holdings make up 61% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$1.6B
Assets (13F)
#1,718
of 8,839 by size
31
Holdings
61%
Top-10 weight
19
Buys
18
Sells
Top holdings · Q2 2026
31 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: NEO
NEOGENOMICS INC
$15.09
−1.31%
11%
12.3M$179.2M
2
NASDAQ: SIBN
SI-BONE INC
$23.75
+0.89%
8.1%
8.1M$132.6M
3
NASDAQ: AXGN
AXOGEN INC
$56.35
−1.05%
7.7%
2.7M$126.9M
4
NASDAQ: APGE
APOGEE THERAPEUTICS INC
$135.07
0.00%
7.5%
930K$123.5M
5
NASDAQ: PVLA
PALVELLA THERAPEUTICS INC
$145.77
−0.55%
7.2%
772K$118.0M
6
NASDAQ: TWST
TWIST BIOSCIENCE CORPORATION
$111.62
−4.07%
4.6%
728K$74.9M
7
NASDAQ: ELVN
ENLIVEN THERAPEUTICS INC
$46.41
+3.39%
4.2%
1.4M$69.1M
8
NASDAQ: GH
GUARDANT HEALTH
$145.59
+0.31%
4.0%
442K$66.3M
9
NASDAQ: MASS
908 DEVICES INC
$9.37
−1.58%
3.3%
6.3M$54.7M
10
NASDAQ: AMLX
AMYLYX PHARMACEUTICALS INC
$26.20
−1.58%
3.3%
3.0M$54.3M
11
NASDAQ: WGS
GENEDX HOLDINGS CORP
$49.24
−5.23%
3.3%
784K$53.8M
12
NASDAQ: SLP
SIMULATIONS PLUS INC
$18.50
0.00%
3.1%
2.8M$51.1M
13
NASDAQ: TNDM
TANDEM DIABETES CARE INC
$16.80
−1.47%
3.1%
3.4M$51.1M
14
NASDAQ: CRNX
CRINETICS PHARMACEUTICALS INC
$84.95
0.00%
3.1%
1.4M$50.9M
15
NASDAQ: NPCE
NEUROPACE INC
$8.14
−0.97%
2.8%
2.9M$45.5M
16
NASDAQ: EWTX
EDGEWISE THERAPEUTICS INC
$41.17
−0.48%
2.7%
1.1M$44.5M
17
NASDAQ: ANAB
ANAPTYS BIO INC
$47.40
+0.72%
2.4%
582K$39.3M
18
NASDAQ: TRVI
TREVI THERAPEUTICS INC
$13.72
+1.55%
2.4%
2.1M$39.1M
19
NASDAQ: SEPN
SEPTERNA INC
$39.20
−0.63%
2.0%
963K$32.3M
20
NASDAQ: TLSI
TRISALUS LIFE SCIENCES INC
$2.18
−11.22%
1.8%
6.6M$29.8M
21
NASDAQ: TECX
TECTONIC THERAPEUTICS INC
$21.04
0.00%
1.7%
801K$27.5M
22
NASDAQ: HCAT
HEALTH CATALYST INC
$1.29
0.00%
1.5%
12.8M$25.5M
23
NYSE: BFLY
BUTTERFLY NETWORK INC
$5.85
−3.78%
1.4%
2.6M$22.2M
24
NASDAQ: ESTA
ESTABLISHMENT LABS HOLDINGS
$69.61
−1.68%
1.3%
247K$21.2M
25
NASDAQ: PCVX
VAXCYTE INC
$58.36
−0.27%
1.2%
345K$20.1M

Showing 1–25 of 31 positions on this page reported in this 13F.

Sector allocation
  • Healthcare100%
Recent activity · vs 2026-03-31
Bought19
  • AddedNEONEOGENOMICS INC+26.2%$179.2M
  • AddedSIBNSI-BONE INC+51.8%$132.6M
  • AddedAPGEAPOGEE THERAPEUTICS INC+61.3%$123.5M
  • AddedELVNENLIVEN THERAPEUTICS INC+574%$69.1M
  • AddedGHGUARDANT HEALTH+57.5%$66.3M
  • AddedMASS908 DEVICES INC+3.5%$54.7M
  • AddedWGSGENEDX HOLDINGS CORP+223%$53.8M
  • AddedSLPSIMULATIONS PLUS INC+6.1%$51.1M
  • AddedTNDMTANDEM DIABETES CARE INC+157%$51.1M
  • AddedCRNXCRINETICS PHARMACEUTICALS INC+24.9%$50.9M
Sold18
  • ReducedAXGNAXOGEN INC−31.3%$126.9M
  • ReducedPVLAPALVELLA THERAPEUTICS INC−21.3%$118.0M
  • ReducedTWSTTWIST BIOSCIENCE CORPORATION−17.2%$74.9M
  • ReducedAMLXAMYLYX PHARMACEUTICALS INC−5.2%$54.3M
  • ReducedHCATHEALTH CATALYST INC−0.5%$25.5M
  • ReducedBFLYBUTTERFLY NETWORK INC−0.7%$22.2M
  • ReducedESTAESTABLISHMENT LABS HOLDINGS−19.9%$21.2M
  • ReducedIRTCIRHYTHM TECHNOLOGIES−0.6%$19.9M
  • ReducedOMCLOMNICELL INC−7.7%$18.8M
  • ReducedATRCATRICURE INC−22.2%$15.9M
5%+ Beneficial Ownership Stakes · 1 activist (13D) · 3 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
HCAT
Health Catalyst, Inc.
13D18.3%13.5MFiled 13 MAR 2026
2
TLSI
TriSalus Life Sciences, Inc.
13G12.0%7.4MFiled 16 NOV 2026
3
AXGN
Axogen, Inc.
13G7.6% · 2 classes4.1MFiled 14 AUG 2026
4
KRMD
KORU Medical Systems, Inc.
13G6.6% · 2 classes2.8MFiled 16 NOV 2026

Showing all 4 disclosed stakes.

Reading First Light Asset Management, LLC’s 13F portfolio

First Light Asset Management, LLC’s $1.6B 13F book is spread across 31 reported positions and is highly concentrated — its ten largest positions alone are 61% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are NEO, SIBN, AXGN, APGE and PVLA, led by NEOGENOMICS INC (NEO) at 11% of the portfolio. The heaviest sector exposure is Healthcare (100%).

What First Light Asset Management, LLC changed last quarter

Between 2026-03-31 and Q2 2026, First Light Asset Management, LLC was roughly balanced between buying and selling: it opened 2 new positions and added to 17 more, while trimming 12 and closing 6 outright. Against a 31-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was NEOGENOMICS INC (NEO), and its biggest reduction was AXOGEN INC (AXGN).

What a 13F does and doesn’t reveal

A 13F captures only First Light Asset Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names First Light Asset Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. First Light Asset Management, LLC's profile on this page is built directly from those filings.

How current is the 13F data on First Light Asset Management, LLC's page?

It reflects First Light Asset Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When First Light Asset Management, LLC files its next quarterly report, this page refreshes automatically.

Can I see First Light Asset Management, LLC's complete list of holdings?

This page highlights First Light Asset Management, LLC's largest positions rather than all 31 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under First Light Asset Management, LLC's filings.

Does a 13F show everything First Light Asset Management, LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of First Light Asset Management, LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why First Light Asset Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.